GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Beijing Strong Biotechnologies 300406.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

12.60

-1.79%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Beijing Strong Biotechnologies

Its shares trade on Shenzhen under the ticker 300406.SZ. It has been listed since 30 October 2014. In the fiscal year to 31 December 2025, it reported revenue of CN¥1.36bn and net income of CN¥189.9m. At that date it held total assets of CN¥5.05bn and shareholders' equity of CN¥3.79bn.

Beijing Strong Biotechnologies, Inc. engages in the research and development, production, and sale of in-vitro diagnostics (IVD) products. The company is headquartered in Beijing, Beijing. The company went IPO on 2014-10-30. The Company’s in vitro diagnostic reagents are mainly used in liver, renal, blood fat, glycometabolism and other fields. The firm is also engaged in the manufacture and sales of in vitro diagnostic equipment and the leasing of equipment. The firm operates businesses in domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
30 Oct 2014
Employees
1,094
Website
bsbe.com.cn ↗

Leadership

Pay as last reported

  • Mr. Zuojun ZouChairman of the Board, since 2011
  • Mr. Wei LiuChief Financial Officer
  • Mr. Qixin LinDeputy General Manager
  • Mr. Qinghai YangDeputy General Manager
  • Mr. Yi ZhangDeputy General Manager
  • Mr. Jianmin WangSecretary of the Board
  • Mr. Xi LiuDirector, since 2011
  • Mr. Aiping LuoDirector
  • Mr. Xiaolin SunDirector
  • Mr. Xiaoya WangDirector
  • Mr. Yonghong ChenIndependent Director
  • Mr. Jianping YangIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Beijing Strong Biotechnologies employs 1,094 full-time employees in the Health Care sector.
  • The company's IVD reagents are used in liver, renal, and blood fat diagnostics.
  • Beijing Strong Biotechnologies operates in both domestic and overseas markets.

Weaknesses

  • The company's IPO was on 30 October 2014, which may indicate limited market history.
  • Beijing Strong Biotechnologies focuses on IVD products without diversification mentioned.
  • The company's business description does not specify product innovation or R&D investment.

Opportunities

  • Expanding IVD markets in liver, renal, and glycometabolism fields offer growth potential.
  • Overseas market operations provide opportunities for international expansion.
  • The Health Care sector's increasing demand for diagnostics supports company growth.

Threats

  • The company's reliance on IVD products may face competition from other diagnostics firms.
  • The Health Care sector is subject to regulatory changes affecting product approvals.
  • Economic downturns could reduce demand for non-essential medical diagnostics.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.